Mina Sagara
Impact in
- Immunology top 5%
- Biomarkers in Disease Mechanisms
- Atherosclerosis and Cardiovascular Diseases
-
- Cardiovascular Health and Disease Prevention
- Cardiac Fibrosis and Remodeling
Papers in
- Immunology 13
- Biomarkers in Disease Mechanisms 13
-
- Climate Change and Health Impacts 1
- Co-authors
- Tatsuhiko Kodama (6 shared papers)Kenji Inoue (2 shared papers)Takao Hamakubo (3 shared papers)Takatoshi Kasai (2 shared papers)Kyoko Miyamoto (5 shared papers)Isao Kubota (1 shared paper)Yo Koyama (1 shared paper)Takeshi Niizeki (1 shared paper)
- Journals
- Thrombosis and Haemostasis (1 paper)Obesity (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Circulation (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)
- Partner nations
- JapanUnited StatesNorway
In The Last Decade
Mina Sagara
13 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 64
- Immunology 805
- Cardiology and Cardiovascular Medicine 108
- Anatomy 7
- Epidemiology 96
- Rehabilitation 15
Countries citing papers authored by Mina Sagara
This map shows the geographic impact of Mina Sagara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Sagara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Sagara more than expected).
Fields of papers citing papers by Mina Sagara
This network shows the impact of papers produced by Mina Sagara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Sagara. The network helps show where Mina Sagara may publish in the future.
Co-authors
The 25 scholars most cited alongside Mina Sagara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 200 | |
| 2 | 2007 | 175 | |
| 3 | 2008 | 170 | |
| 4 | 2009 | 130 | |
| 5 | 2008 | 77 | |
| 6 | 2010 | 66 | |
| 7 | 2010 | 62 | |
| 8 | 2010 | 51 | |
| 9 | 2009 | 38 | |
| 10 | 2007 | 35 | |
| 11 | 2007 | 32 | |
| 12 | 2009 | 26 | |
| 13 | Abstract 1725: Long Pentraxin3 (PTX3) is More Specific than CRP as a Marker for Vascular Inflammation | 2007 | 1 |
About Mina Sagara
Mina Sagara is a scholar working on Immunology, Health, Toxicology and Mutagenesis, Physiology, Infectious Diseases and Organic Chemistry, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Biomarkers in Disease Mechanisms (13 papers), Climate Change and Health Impacts (1 paper) and Thermoregulation and physiological responses (1 paper). The work is most often cited by research in Immunology (805 citations), Cardiology and Cardiovascular Medicine (108 citations), Anatomy (7 citations), Epidemiology (96 citations) and Rehabilitation (15 citations). Mina Sagara has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include Tatsuhiko Kodama, Kenji Inoue, Takao Hamakubo, Takatoshi Kasai, Kyoko Miyamoto, Isao Kubota, Yo Koyama, Takeshi Niizeki, Yasuchika Takeishi and Kazumi Yamasaki. Their work appears in journals such as Thrombosis and Haemostasis, Obesity, Arteriosclerosis Thrombosis and Vascular Biology, Circulation and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.